Submit Your Article CMED MEACR meeting
An official publication of the Middle-Eastern Association for Cancer Research
Clinical Cancer Investigation Journal
ISSN Print: 2278-1668, Online: 2278-0513
ARTICLE
Year: 2016   |   Volume: 5   |   Issue: 1   |   Page: 52-55     View issue

Multiple endocrine neoplasia-2A-revisited


, , , , ,
Abstract

Multiple endocrine neoplasia-2A (MEN-2A) is a rare syndrome. MEN-2 is characterized by medullary thyroid carcinoma (MTC), pheochromocytoma, and hyperparathyroidism. MTC is the most consistent feature in all subtypes of MEN-2. In MEN-2A, approximately 70–95% of individuals develop MTC, 50% develop pheochromocytoma, and 15–30% develop hyperparathyroidism. Identification of a germline REarranged in transfection mutation or the identification of the clinical features of MEN-2A in other first-degree relatives is required to make the diagnosis, in those patients with only one or two clinical features. We present the case of a family with MEN-2A syndrome. Here, the patient was first operated for MTC and following further investigation was detected to have pheochromocytoma. In her family history, she had a daughter who was earlier operated for MTC. After 5 years of follow-up, she is doing well. This is an additional case of MEN-2A.

Cite this article
Vancouver
Jena A, Patnayak R, Vaikkakara S, Sachan A, Vijaylaxmi B, Manilal B. Multiple endocrine neoplasia-2A-revisited. Clin Cancer Investig J. 2016;5(1):52-5. https://doi.org/10.4103/2278-0513.172075
APA
Jena, A., Patnayak, R., Vaikkakara, S., Sachan, A., Vijaylaxmi, B., & Manilal, B. (2016). Multiple endocrine neoplasia-2A-revisited. Clinical Cancer Investigation Journal, 5(1), 52-55. https://doi.org/10.4103/2278-0513.172075

Copyright © 2024 Clinical Cancer Investigation Journal, All rights are reserved and for all open access contents, the Creative Commons licensing terms apply.
Online since 01 December, 2011
Creative Commons License 
ISSN Print: 2278-1668, Online: 2278-0513